Cargando…
Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
Chronic kidney disease (CKD) results in the accumulation of metabolic waste products that are normally cleared by the kidney, known as uremia. Many of these waste products are from bacteria metabolites in the gut. Accumulation of uremic toxins in plasma and tissue, as well as the gut-plasma-tissue m...
Autores principales: | Velenosi, Thomas J., Hennop, Anzel, Feere, David A., Tieu, Alvin, Kucey, Andrew S., Kyriacou, Polydoros, McCuaig, Laura E., Nevison, Stephanie E., Kerr, Michael A., Urquhart, Bradley L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773761/ https://www.ncbi.nlm.nih.gov/pubmed/26932318 http://dx.doi.org/10.1038/srep22526 |
Ejemplares similares
-
The effect of chronic kidney disease on CYP2B expression and activity in male Wistar rats
por: Kucey, Andrew S., et al.
Publicado: (2019) -
Metabolomic Response of Skeletal Muscle to Aerobic Exercise Training in Insulin Resistant Type 1 Diabetic Rats
por: Dotzert, Michelle S., et al.
Publicado: (2016) -
AST-120 for the management of progression of chronic kidney disease
por: Schulman, Gerald, et al.
Publicado: (2014) -
Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function
por: Velenosi, Thomas J., et al.
Publicado: (2019) -
Effect of AST-120 on Endothelial Dysfunction in Adenine-Induced Uremic Rats
por: Inami, Yuko, et al.
Publicado: (2014)